nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
|
Earl, Helena M |
|
|
18 |
6 |
p. 755-769 |
artikel |
2 |
Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study
|
Atkin, Wendy |
|
|
18 |
6 |
p. 823-834 |
artikel |
3 |
Adopting a new stance on immunotherapy for uveal melanoma
|
Komatsubara, Kimberly M |
|
|
18 |
6 |
p. 702-704 |
artikel |
4 |
A new standard of care or just another option for patients with relapsed ovarian cancer?
|
Harter, Philipp |
|
|
18 |
6 |
p. 701-702 |
artikel |
5 |
Art and emotion in health care
|
Zektzer, Carly |
|
|
18 |
6 |
p. 716 |
artikel |
6 |
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
|
Coleman, Robert L |
|
|
18 |
6 |
p. 779-791 |
artikel |
7 |
Brigatinib effective in ALK-positive non-small-cell lung cancer
|
Das, Manjulika |
|
|
18 |
6 |
p. e310 |
artikel |
8 |
Cancer Drugs Fund of minimal benefit
|
Burki, Talha Khan |
|
|
18 |
6 |
p. e305 |
artikel |
9 |
Cancer Rhapsody
|
Mariotti, Laura |
|
|
18 |
6 |
p. 715 |
artikel |
10 |
Can post-polypectomy surveillance be less intensive?
|
Winawer, Sidney J |
|
|
18 |
6 |
p. 707-709 |
artikel |
11 |
CAR T-cell therapy effective in B acute lymphoblastic leukaemia
|
Wang, Mai |
|
|
18 |
6 |
p. e314 |
artikel |
12 |
Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer
|
Carvalho, Carlos |
|
|
18 |
6 |
p. e354-e363 |
artikel |
13 |
Chernobyl's tomb
|
Burki, Talha Khan |
|
|
18 |
6 |
p. 718 |
artikel |
14 |
Correction to Lancet Oncol 2017; 18: 719–31
|
|
|
|
18 |
6 |
p. e301 |
artikel |
15 |
Correction to Lancet Oncol 2017; 18: 63–74
|
|
|
|
18 |
6 |
p. e301 |
artikel |
16 |
Correction to Lancet Oncol 2017; 18: 812
|
|
|
|
18 |
6 |
p. e301 |
artikel |
17 |
Cracking the cancer code: a personalised genomic approach
|
Lucas, Catherine |
|
|
18 |
6 |
p. 717 |
artikel |
18 |
Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy?
|
Shah, Ravi M |
|
|
18 |
6 |
p. e291 |
artikel |
19 |
Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? – Authors' reply
|
Schmiegelow, Kjeld |
|
|
18 |
6 |
p. e292 |
artikel |
20 |
Electronic cigarette use in the UK
|
Burki, Talha Khan |
|
|
18 |
6 |
p. e311 |
artikel |
21 |
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|
Weller, Michael |
|
|
18 |
6 |
p. e315-e329 |
artikel |
22 |
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
|
Pace, Andrea |
|
|
18 |
6 |
p. e330-e340 |
artikel |
23 |
European Association for the Study of the Liver: International Liver Congress 2017 Meeting
|
Fricker, Janet |
|
|
18 |
6 |
p. 713 |
artikel |
24 |
Evolving adoptive cellular therapies in urological malignancies
|
Wong, Yien Ning Sophia |
|
|
18 |
6 |
p. e341-e353 |
artikel |
25 |
Evolving health-care regulations in China
|
Ouyang, Yadan |
|
|
18 |
6 |
p. 714 |
artikel |
26 |
“Finding NEMO” in NRAS-mutant melanoma: a step towards a sequential strategy?
|
Bersanelli, Melissa |
|
|
18 |
6 |
p. e298 |
artikel |
27 |
Genetics of gallbladder cancer
|
Hemminki, Kari |
|
|
18 |
6 |
p. e296 |
artikel |
28 |
Genetics of gallbladder cancer – Authors' reply
|
Mhatre, Sharayu |
|
|
18 |
6 |
p. e297 |
artikel |
29 |
Glio, and the family Stone
|
Morgan, Jules |
|
|
18 |
6 |
p. 715 |
artikel |
30 |
Graphing individual cancer experiences with Cancergraph
|
Jenkins, Emily |
|
|
18 |
6 |
p. 718 |
artikel |
31 |
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|
Gronchi, Alessandro |
|
|
18 |
6 |
p. 812-822 |
artikel |
32 |
HPV-related oropharyngeal carcinoma de-escalation protocols
|
Mesía, Ricard |
|
|
18 |
6 |
p. 704-705 |
artikel |
33 |
Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement
|
Denburg, Avram |
|
|
18 |
6 |
p. 709-711 |
artikel |
34 |
Incidence and prognosis of carcinoid syndrome: hormones or tumour burden?
|
Zandee, Wouter T |
|
|
18 |
6 |
p. e299 |
artikel |
35 |
Incidence and prognosis of carcinoid syndrome: hormones or tumour burden? – Authors' reply
|
Halperin, Daniel M |
|
|
18 |
6 |
p. e300 |
artikel |
36 |
International incidence of childhood cancer, 2001–10: a population-based registry study
|
Steliarova-Foucher, Eva |
|
|
18 |
6 |
p. 719-731 |
artikel |
37 |
Malignancy in a child or something else?
|
Hoyer-Kuhn, Heike |
|
|
18 |
6 |
p. e364 |
artikel |
38 |
Naldemedine effective in treating opioid-induced constipation
|
Brower, Vicki |
|
|
18 |
6 |
p. e306 |
artikel |
39 |
Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?
|
van der Graaf, Winette T A |
|
|
18 |
6 |
p. 706-707 |
artikel |
40 |
Neoadjuvant chemotherapy: survival benefit in gastric cancer
|
Das, Manjulika |
|
|
18 |
6 |
p. e307 |
artikel |
41 |
New drug-transfer device reduces hazardous exposure
|
Gourd, Elizabeth |
|
|
18 |
6 |
p. e312 |
artikel |
42 |
Pfizer to make palbociclib temporarily free on NHS
|
Burki, Talha Khan |
|
|
18 |
6 |
p. e309 |
artikel |
43 |
Pregnancy complications in survivors of childhood cancer
|
Brower, Vicki |
|
|
18 |
6 |
p. e303 |
artikel |
44 |
Preventing prevention: Indian politics and public health clash
|
The Lancet Oncology, |
|
|
18 |
6 |
p. 695 |
artikel |
45 |
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
|
Chen, Allen M |
|
|
18 |
6 |
p. 803-811 |
artikel |
46 |
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
|
Alistar, Angela |
|
|
18 |
6 |
p. 770-778 |
artikel |
47 |
Selumetinib does not improve survival outcomes in NSCLC
|
Das, Manjulika |
|
|
18 |
6 |
p. e313 |
artikel |
48 |
Short-course radiotherapy with delayed surgery for rectal cancer
|
Xie, Li |
|
|
18 |
6 |
p. e294 |
artikel |
49 |
Short-course radiotherapy with delayed surgery for rectal cancer
|
Kurokawa, Tomohiro |
|
|
18 |
6 |
p. e293 |
artikel |
50 |
Short-course radiotherapy with delayed surgery for rectal cancer – Authors' reply
|
Erlandsson, Johan |
|
|
18 |
6 |
p. e295 |
artikel |
51 |
Switch to exemestane effective in early breast cancer
|
Gourd, Elizabeth |
|
|
18 |
6 |
p. e308 |
artikel |
52 |
Targeting metabolism in pancreatic cancer
|
Michalski, Christoph W |
|
|
18 |
6 |
p. 699-700 |
artikel |
53 |
The tAnGo fell short of inspiring the audience
|
Mavroudis, Dimitrios |
|
|
18 |
6 |
p. 698-699 |
artikel |
54 |
Trastuzumab emtansine in HER2-positive metastatic breast cancer
|
Montemurro, Filippo |
|
|
18 |
6 |
p. 696-697 |
artikel |
55 |
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
|
Diéras, Véronique |
|
|
18 |
6 |
p. 732-742 |
artikel |
56 |
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
|
Krop, Ian E |
|
|
18 |
6 |
p. 743-754 |
artikel |
57 |
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
|
Chandran, Smita S |
|
|
18 |
6 |
p. 792-802 |
artikel |
58 |
Treatment options for early-stage Hodgkin's lymphoma
|
Venkatesan, Priya |
|
|
18 |
6 |
p. e304 |
artikel |
59 |
Tyrosine kinase-inhibitors and heart failure risk
|
Das, Manjulika |
|
|
18 |
6 |
p. e302 |
artikel |
60 |
Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer
|
Tseng, Jennifer |
|
|
18 |
6 |
p. 711-712 |
artikel |